尿検査の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

尿検査市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の尿検査市場規模は2025～2030年にかけてCAGR 7.83%で拡大し、2030年には68億5,000万米ドルに達する見込みです。

世界の尿路結石の罹患率増加が市場成長に寄与SHEA誌が発表した調査によると、2021年には、尿検査の約60％から70％が、消化管（GU）に関連する症状のない患者に実施されています。

先進国と新興国市場における高齢者の増加とそれに伴う加齢関連疾患の増加は、尿検査市場の成長にプラスの影響を与えると考えられます。世界保健機関（WHO）によると、高齢者は2020年の10億人から2021年には14億人に増加します。高齢者における慢性疾患の早期診断と管理が、ビリルビン、ケトン体、グルコース、クレアチニンなどの検査の配合率増加の原因となっています。これらの検査は尿検査によって実施されるため、市場成長の原動力になると予想されます。

さらに、腎臓や肝臓などの移植手術を受ける患者には、尿路感染症（UTI）を避けるために術前に尿検査を受けることが推奨されることが多いです。United Network for Organ Sharingのデータによると、米国では2021年に約2万4,669件の腎臓移植、9,236件の肝臓移植、3,817件の心臓移植が行われました。このように、移植手術の増加は市場の成長を促進すると予想されます。

企業は、技術的に先進的な尿検査製品の開発と販売のために、提携や戦略的パートナーシップなどのイニシアチブをとっています。例えば、2021年10月、Sysmexは最高レベルの自動尿検査ワークフローソリューションの開発のため、Inpecoと協業を開始しました。この製品は、SysmexのUNシリーズとインペコの尿検査ソリューションのFlexLab TMトラックの助けを借りて開発されました。この製品は、検査室がワークフローサポートを最適化し、最高の患者ケアを提供できるよう支援する唯一の完全オープンオートメーションシステムです。

尿検査市場レポートハイライト

• 2024年の売上高では、消耗品セグメントが78.56%と圧倒的な収益シェアを占めています。この優位性は、臨床検査室と病院検査室による試薬とディップスティックの需要増加と頻繁な購入に起因しています。
• 尿路感染スクリーニングセグメントは市場を独占し、2024年には24.07%の収益シェアを占めました。
• 臨床検査部門は、2024年に約45.88%の最も高い収益シェアを占めました。これは、患者へのアクセスが容易であることと、これらの検査室で先進的製品が利用可能であることに起因します。
• 北米の尿検査市場は市場を独占し、2024年には37.9%の最大の収益シェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 尿検査市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 尿検査市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 尿検査市場：製品別、推定・動向分析

• 世界の尿検査市場：製品ダッシュボード
• 世界の尿検査市場：製品変動分析
• 世界の尿検査市場：製品別、収益別
• 機器
• 生化学尿分析装置
  • 自動生化学分析装置
  • 半自動尿沈殿物分析装置
• 自動尿沈殿物分析装置
  • 顕微鏡尿分析装置
  • フローサイトメトリー尿分析装置
• 消耗品
• ディップスティック
• 試薬
• 使い捨て

第5章 尿検査市場：用途別、推定・動向分析

• 世界の尿検査市場：用途ダッシュボード
• 世界の尿検査市場：用途変動分析
• 世界の尿検査市場：用途別、収益別
• 尿路感染
• 糖尿病
• 腎臓病
• 高血圧
• 肝臓病
• その他

第6章 尿検査市場：最終用途別、推定・動向分析

• 世界の尿検査市場：最終用途ダッシュボード
• 世界の尿検査市場：最終用途変動分析
• 世界の尿検査市場：最終用途別、収益別
• 病院
• 臨床検査
• 在宅医療
• 研究と学術
• その他

第7章 尿検査市場：製品、用途、最終用途による地域別、推定・動向分析

• 地域ダッシュボード
• 市場規模、予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要販売代理店とチャネルパートナー一覧
  • 主要企業の市場シェア分析、2024年
  • Abbott
  • Sysmex Corporation
  • Siemens Healthineers AG
  • ACON Laboratories, Inc.
  • ARKRAY Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Quidel Corporation
  • Bio-Rad Laboratories, Inc.

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 4 Global Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 5 Global Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 6 Global Urinalysis, by Region, 2018 - 2030 (USD Billion)
• Table 7 North America Urinalysis, by Country, 2018 - 2030 (USD Billion)
• Table 8 North America Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 9 North America Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 10 North America Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 11 U.S. Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 12 U.S. Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 13 U.S. Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 14 Canada Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 15 Canada Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 16 Canada Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 17 Mexico Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 18 Mexico Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 19 Mexico Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 20 Europe Urinalysis, by Country, 2018 - 2030 (USD Billion)
• Table 21 Europe Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 22 Europe Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 23 Europe Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 24 Germany Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 25 Germany Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 26 Germany Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 27 UK Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 28 UK Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 29 UK Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 30 France Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 31 France Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 32 France Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 33 Italy Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 34 Italy Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 35 Italy Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 36 Spain Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 37 Spain Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 38 Spain Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 39 Denmark Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 40 Denmark Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 41 Denmark Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 42 Sweden Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 43 Sweden Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 44 Sweden Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 45 Norway Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 46 Norway Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 47 Norway Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 48 Asia Pacific Urinalysis, by Country, 2018 - 2030 (USD Billion)
• Table 49 Asia Pacific Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 50 Asia Pacific Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 51 Asia Pacific Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 52 China Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 53 China Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 54 China Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 55 Japan Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 56 Japan Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 57 Japan Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 58 India Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 59 India Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 60 India Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 61 South Korea Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 62 South Korea Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 63 South Korea Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 64 Australia Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 65 Australia Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 66 Australia Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 67 Thailand Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 68 Thailand Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 69 Thailand Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 70 Latin America Urinalysis, by Country, 2018 - 2030 (USD Billion)
• Table 71 Latin America Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 72 Latin America Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 73 Latin America Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 74 Brazil Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 75 Brazil Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 76 Brazil Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 77 Argentina Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 78 Argentina Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 79 Argentina Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 80 Middle East & Africa Urinalysis, by Country, 2018 - 2030 (USD Billion)
• Table 81 Middle East & Africa Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 82 Middle East & Africa Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 83 Middle East & Africa Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 84 South Africa Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 85 South Africa Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 86 South Africa Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 87 Saudi Arabia Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 88 Saudi Arabia Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 89 Saudi Arabia Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 90 UAE Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 91 UAE Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 92 UAE Urinalysis, by End Use, 2018 - 2030 (USD Billion)
• Table 93 Kuwait Urinalysis, by Product, 2018 - 2030 (USD Billion)
• Table 94 Kuwait Urinalysis, by Application, 2018 - 2030 (USD Billion)
• Table 95 Kuwait Urinalysis, by End Use, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Urinalysis Market Segmentation
• Fig. 8 Market Snapshot, 2024
• Fig. 9 Market Trends & Outlook
• Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 14 Porter's Five Forces Analysis
• Fig. 15 Global Urinalysis Market: Product Movement Analysis
• Fig. 16 Global Urinalysis Market, for Instruments, 2018 - 2030 (USD Billion)
• Fig. 17 Global Urinalysis Market, for Biochemical Urine Analyzer, 2018 - 2030 (USD Billion)
• Fig. 18 Global Urinalysis Market, for Automated Biochemical Analyzers, 2018 - 2030 (USD Billion)
• Fig. 19 Global Urinalysis Market, for Semi-automated Urine Sediment Analyzers, 2018 - 2030 (USD Billion)
• Fig. 20 Global Urinalysis Market, for Automated Urine Sediment Analyzers, 2018 - 2030 (USD Billion)
• Fig. 21 Global Urinalysis Market, for Microscopic Urine Analyzers, 2018 - 2030 (USD Billion)
• Fig. 22 Global Urinalysis Market, for Flowcytometric Urine Analyzers, 2018 - 2030 (USD Billion)
• Fig. 23 Global Urinalysis Market, for Consumables, 2018 - 2030 (USD Billion)
• Fig. 24 Global Urinalysis Market, for Dipsticks, 2018 - 2030 (USD Billion)
• Fig. 25 Global Urinalysis Market, for Reagents, 2018 - 2030 (USD Billion)
• Fig. 26 Global Urinalysis Market, for Disposables, 2018 - 2030 (USD Billion)
• Fig. 27 Global Urinalysis Market, for Application, 2018 - 2030 (USD Billion)
• Fig. 28 Global Urinalysis Market, for UTI Screening, 2018 - 2030 (USD Billion)
• Fig. 29 Global Urinalysis Market, for Diabetes, 2018 - 2030 (USD Billion)
• Fig. 30 Global Urinalysis Market, for Kidney Disease, 2018 - 2030 (USD Billion)
• Fig. 31 Global Urinalysis Market, for Hypertension, 2018 - 2030 (USD Billion)
• Fig. 32 Global Urinalysis Market, for Liver Disease, 2018 - 2030 (USD Billion)
• Fig. 33 Global Urinalysis Market, for Others, 2018 - 2030 (USD Billion)
• Fig. 34 Global Urinalysis Market: End Use Movement Analysis
• Fig. 35 Global Urinalysis Market, for Hospitals, 2018 - 2030 (USD Billion)
• Fig. 36 Global Urinalysis Market, for Clinical Laboratories, 2018 - 2030 (USD Billion)
• Fig. 37 Global Urinalysis Market, for Home Care, 2018 - 2030 (USD Billion)
• Fig. 38 Global Urinalysis Market, for Research and Academics, 2018 - 2030 (USD Billion)
• Fig. 39 Global Urinalysis Market, for Others, 2018 - 2030 (USD Billion)
• Fig. 40 Regional Marketplace: Key Takeaways
• Fig. 41 Regional Outlook, 2024 & 2030
• Fig. 42 Global Urinalysis Market: Region Movement Analysis
• Fig. 43 North America Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 44 U.S. Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 45 Canada Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 46 Mexico Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 47 Europe Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 48 Germany Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 49 UK Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 50 France Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 51 Italy Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 52 Spain Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 53 Denmark Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 54 Sweden Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 55 Norway Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 56 Asia Pacific Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 57 Japan Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 58 China Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 59 India Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 60 Australia Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 61 South Korea Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 62 Thailand Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 63 Latin America Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 64 Brazil Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 65 Argentina Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 66 Middle East and Africa Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 67 South Africa Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 68 Saudi Arabia Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 69 UAE Urinalysis Market, 2018 - 2030 (USD Billion)
• Fig. 70 Kuwait Urinalysis Market, 2018 - 2030 (USD Billion)

Urinalysis Market Growth & Trends:

The global urinalysis market size is expected to reach USD 6.85 billion by 2030, expanding at a CAGR of 7.83% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of UTI worldwide contributes to market growth. According to a study published by SHEA journal, in 2021, approximately 60% to 70% of urinalyses were being performed in patients without symptoms referable to the Gastrointestinal Tract (GU).

Increasing geriatric population and the subsequent increase in age related diseases in developed and developing regions will positively influence urinalysis market growth. According to the World Health Organization (WHO), the geriatric population increased from 1 billion in 2020 to 1.4 billion in 2021. The early diagnosis and management of chronic diseases in geriatric population is responsible for the increasing prescription rate for tests such as bilirubin, ketones, glucose, and creatinine. These tests are performed by urinalysis; hence, it is anticipated to drive market growth.

Moreover, for patients undergoing transplant surgeries including kidney and liver, transplant procedures is often recommended to undergo preoperative urinalysis to avoid urinary tract infections (UTIs). According to United Network for Organ Sharing data, around 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplants were performed in the U.S. in 2021. Thus, an increasing number of transplant surgeries is expected to fuel market growth.

Companies are taking initiatives such as collaboration and strategic partnerships for the development and marketing of technologically advanced urinalysis products. For instance, in October 2021, Sysmex entered into collaboration with Inpeco for the development of an automated urinalysis workflow solution of the highest level. This product was developed with a help of UN-Series of Sysmex's and FlexLab TM track of Inpeco's urinalysis solutions. It is the only fully open automation system that helps laboratories optimize their workflow support and provide premium patient care.

Urinalysis Market Report Highlights:

• The consumables segment held the dominant revenue share of 78.56% in terms of revenue in 2024. This dominance can be attributed to the increasing demand and frequent purchases of reagents and dipsticks by clinical and hospital laboratories.
• The urinary tract infection screening segment dominated the market and accounted for a revenue share of 24.07% in 2024, due to the rising incidence of UTIs worldwide.
• The clinical laboratories segment accounted for the highest revenue share of around 45.88% in 2024. This can be attributed to their easy accessibility to patients and the availability of advanced products in these laboratories.
• North America urinalysis market dominated the market and accounted for the largest revenue share of 37.9% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product, application and end-use outlook
  • 2.2.2. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Urinalysis Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of chronic and infectious diseases
    • 3.2.1.2. Technological advancements in urinalysis devices
    • 3.2.1.3. Rising geriatric population
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of advanced urinalysis equipment
• 3.3. Urinalysis Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Social landscape
    • 3.3.2.5. Environmental landscape

Chapter 4. Urinalysis Market: Product Estimates & Trend Analysis

• 4.1. Global Urinalysis Market: Product Dashboard
• 4.2. Global Urinalysis Market: Product Movement Analysis
• 4.3. Global Urinalysis Market by Product , Revenue
• 4.4. Instruments
• 4.5. Biochemical Urine Analyzer
  • 4.5.1. Biochemical urine analyzer market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5.2. Automated Biochemical Analyzers
    • 4.5.2.1. Automated biochemical analyzers market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5.3. Semi-automated Urine Sediment Analyzers
    • 4.5.3.1. Semi-automated urine sediment analyzers market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.6. Automated Urine Sediment Analyzers
  • 4.6.1. Automated urine sediment analyzers market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.6.2. Microscopic Urine Analyzers
    • 4.6.2.1. Microscopic urine analyzers market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.6.3. Flowcytometric Urine Analyzers
    • 4.6.3.1. Flowcytometric urine analyzers market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.7. Consumables
• 4.8. Dipsticks
  • 4.8.1. Dipsticks market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.9. Reagents
  • 4.9.1. Reagents market estimates and forecasts 2018 to 2030 (USD Billion)
• 4.10. Disposables
  • 4.10.1. Disposables market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Urinalysis Market: Application Estimates & Trend Analysis

• 5.1. Global Urinalysis Market: Application Dashboard
• 5.2. Global Urinalysis Market: Application Movement Analysis
• 5.3. Global Urinalysis Market by Application , Revenue
• 5.4. UTI Screening
  • 5.4.1. UTI screening market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.5. Diabetes
  • 5.5.1. Diabetes market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.6. Kidney Disease
  • 5.6.1. Kidney disease market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.7. Hypertension
  • 5.7.1. Hypertension market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.8. Liver Disease
  • 5.8.1. Liver disease market estimates and forecasts 2018 to 2030 (USD Billion)
• 5.9. Others
  • 5.9.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Urinalysis Market: End Use Estimates & Trend Analysis

• 6.1. Global Urinalysis Market: End Use Dashboard
• 6.2. Global Urinalysis Market: End Use Movement Analysis
• 6.3. Global Urinalysis Market by End Use, Revenue
• 6.4. Hospitals
  • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Billion)
• 6.5. Clinical Laboratories
  • 6.5.1. Clinical laboratories market estimates and forecasts 2018 to 2030 (USD Billion)
• 6.6. Home Care
  • 6.6.1. Home care market estimates and forecasts 2018 to 2030 (USD Billion)
• 6.7. Research and Academics
  • 6.7.1. Research and academics market estimates and forecasts 2018 to 2030 (USD Billion)
• 6.8. Others
  • 6.8.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Urinalysis Market: Regional Estimates & Trend Analysis by Product, Application, and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Billion)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2024
  • 8.3.4. Abbott
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Sysmex Corporation
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Siemens Healthineers AG
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. ACON Laboratories, Inc.
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. ARKRAY Inc.
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. F. Hoffmann-La Roche Ltd.
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Quidel Corporation
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Bio-Rad Laboratories, Inc.
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives